Cargando…

Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a growing economic burden worldwide. Smoking cessation is thought to be the single most effective way of reducing the economic burden of COPD. The impact of other strategies such as interventions that predict risk of disease, reduce progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Najafzadeh, Mehdi, Marra, Carlo A., Lynd, Larry D., Sadatsafavi, Mohsen, FitzGerald, J. Mark, McManus, Bruce, Sin, Don
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469627/
https://www.ncbi.nlm.nih.gov/pubmed/23071626
http://dx.doi.org/10.1371/journal.pone.0046746
_version_ 1782246118938116096
author Najafzadeh, Mehdi
Marra, Carlo A.
Lynd, Larry D.
Sadatsafavi, Mohsen
FitzGerald, J. Mark
McManus, Bruce
Sin, Don
author_facet Najafzadeh, Mehdi
Marra, Carlo A.
Lynd, Larry D.
Sadatsafavi, Mohsen
FitzGerald, J. Mark
McManus, Bruce
Sin, Don
author_sort Najafzadeh, Mehdi
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a growing economic burden worldwide. Smoking cessation is thought to be the single most effective way of reducing the economic burden of COPD. The impact of other strategies such as interventions that predict risk of disease, reduce progression of disease, or reduce exacerbations has not been systematically studied. OBJECTIVES: We estimated the economic and clinical burden of COPD over the next 25 years in Canada and the impact of three potential interventions (screening test for predisposition to COPD, new drugs to avoid progression into more severe disease stages, and predictive test for exacerbations) on COPD burden. METHODS: Using a dynamic simulation model, we projected the total burden of COPD (cost, morbidity, and mortality) from 2011 to 2035 using the population of Canada as a case study. The model stratified population based on sex, age, smoking status, respiratory symptoms, and their COPD stage. The cost and quality adjusted life years (QALYs) associated with each intervention were estimated. RESULTS: The model indicates that annual societal cost of COPD is $4.52 billion (B) Canadian dollars in 2011 and will reach $3.61B ($7.33B undiscounted) per year in 2035. Over the next 25 years, COPD will be responsible for approximately $101.4B in societal costs ($147.5B undiscounted) and 12.9 million QALYs lost (19.0 million undiscounted). Our results suggested that the best strategy to reduce the financial burden of COPD is by reducing exacerbations. Smoking cessation, while it is the cornerstone of COPD prevention, has only a modest effect in attenuating the financial burden of COPD over the next 25 years in Western countries such as Canada. CONCLUSION: Our data suggest that any intervention that can reduce the number of exacerbations has a substantial impact on morbidity and costs of COPD and should be considered in conjunction with the ongoing efforts to reduce smoking rates.
format Online
Article
Text
id pubmed-3469627
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34696272012-10-15 Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model Najafzadeh, Mehdi Marra, Carlo A. Lynd, Larry D. Sadatsafavi, Mohsen FitzGerald, J. Mark McManus, Bruce Sin, Don PLoS One Research Article BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a growing economic burden worldwide. Smoking cessation is thought to be the single most effective way of reducing the economic burden of COPD. The impact of other strategies such as interventions that predict risk of disease, reduce progression of disease, or reduce exacerbations has not been systematically studied. OBJECTIVES: We estimated the economic and clinical burden of COPD over the next 25 years in Canada and the impact of three potential interventions (screening test for predisposition to COPD, new drugs to avoid progression into more severe disease stages, and predictive test for exacerbations) on COPD burden. METHODS: Using a dynamic simulation model, we projected the total burden of COPD (cost, morbidity, and mortality) from 2011 to 2035 using the population of Canada as a case study. The model stratified population based on sex, age, smoking status, respiratory symptoms, and their COPD stage. The cost and quality adjusted life years (QALYs) associated with each intervention were estimated. RESULTS: The model indicates that annual societal cost of COPD is $4.52 billion (B) Canadian dollars in 2011 and will reach $3.61B ($7.33B undiscounted) per year in 2035. Over the next 25 years, COPD will be responsible for approximately $101.4B in societal costs ($147.5B undiscounted) and 12.9 million QALYs lost (19.0 million undiscounted). Our results suggested that the best strategy to reduce the financial burden of COPD is by reducing exacerbations. Smoking cessation, while it is the cornerstone of COPD prevention, has only a modest effect in attenuating the financial burden of COPD over the next 25 years in Western countries such as Canada. CONCLUSION: Our data suggest that any intervention that can reduce the number of exacerbations has a substantial impact on morbidity and costs of COPD and should be considered in conjunction with the ongoing efforts to reduce smoking rates. Public Library of Science 2012-10-11 /pmc/articles/PMC3469627/ /pubmed/23071626 http://dx.doi.org/10.1371/journal.pone.0046746 Text en © 2012 Najafzadeh et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Najafzadeh, Mehdi
Marra, Carlo A.
Lynd, Larry D.
Sadatsafavi, Mohsen
FitzGerald, J. Mark
McManus, Bruce
Sin, Don
Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model
title Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model
title_full Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model
title_fullStr Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model
title_full_unstemmed Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model
title_short Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model
title_sort future impact of various interventions on the burden of copd in canada: a dynamic population model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469627/
https://www.ncbi.nlm.nih.gov/pubmed/23071626
http://dx.doi.org/10.1371/journal.pone.0046746
work_keys_str_mv AT najafzadehmehdi futureimpactofvariousinterventionsontheburdenofcopdincanadaadynamicpopulationmodel
AT marracarloa futureimpactofvariousinterventionsontheburdenofcopdincanadaadynamicpopulationmodel
AT lyndlarryd futureimpactofvariousinterventionsontheburdenofcopdincanadaadynamicpopulationmodel
AT sadatsafavimohsen futureimpactofvariousinterventionsontheburdenofcopdincanadaadynamicpopulationmodel
AT fitzgeraldjmark futureimpactofvariousinterventionsontheburdenofcopdincanadaadynamicpopulationmodel
AT mcmanusbruce futureimpactofvariousinterventionsontheburdenofcopdincanadaadynamicpopulationmodel
AT sindon futureimpactofvariousinterventionsontheburdenofcopdincanadaadynamicpopulationmodel